UnitedHealth: When The Tide Goes, Only Financials Will Remain (Technical Analysis)

  • UNH's sharp decline to $250 is a buying opportunity, supported by strong revenue growth, stable profitability, and resilient dividends. Despite legal and management uncertainties, UNH's financials remain robust, with no operational issues and a forward P/E at historic lows. Dividend growth remains attractive, and my analysis projects strong yield on cost for long-term investors, even in conservative scenarios.